Delivery Order SPE2DB20D1051-SPE2DB25FD8ZB
- Not listed
- The Defense Logistics Agency awarded a $4,196.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Insulin Aspart 100 Unit/mL vials (10mL) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Insulin Aspart 100 Unit/mL vials (10mL) with a ceiling value of $2,262.05. This is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and represents a non-competitive set-aside contract. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $1,943.52 Firm Fixed Price Delivery Order is for the supply of Insulin Aspart 100 Unit/mL vials. The contract has an ultimate completion date of April 22, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $20,200.75 contract is for the supply of Insulin Aspart 100 Unit/ML Vials, 10ML, with an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,195.52, is for the provision of Insulin Aspart 100 unit/mL pens with a completion date of January 31, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is part of a larger indefinite delivery...
- This is a $1,499.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/mL Vial 10mL. The contract has an ultimate completion date of April 2, 2025 and is not associated with a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,822.60, is for the delivery of Insulin Aspart 100 Unit/ML Vials 10ML to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of Insulin Aspart 100 Unit/mL vials with a 10mL volume. The $6,354.84 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, and has an ultimate completion date of May 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of insulin aspart medication in 10 mL vials. The $9,896.55 delivery order contract, placed by the Defense Logistics Agency (DLA), has a firm fixed price and an ultimate completion date of April 22, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $6,586.56 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 4563456132 - INSULIN ASPART 100 UNIT/ML PEN 3ML. This delivery order is part of an indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies to military treatment facilities worldwide. The contract does not...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB25FD8ZBDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 1, 2025, for the supply of Insulin Aspart 100 Unit/mL vials (10mL) with a ceiling value of $1,144.07. This competitively awarded, non-set-aside contract operates under firm fixed pricing and carries an ultimate completion date of August 4, 2025. The place of performance is located in Conshohocken, PA, aligning with AmerisourceBergen's corporate headquarters and distribution operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a global pharmaceutical support vehicle enabling the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, medical devices, and specialized healthcare commodities. The contract supports critical federal medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/1/25 |